These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 12173015

  • 1. Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data.
    Keith CJ, Miles KA, Griffiths MR, Wong D, Pitman AG, Hicks RJ.
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1016-23. PubMed ID: 12173015
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.
    Dietlein M, Weber K, Gandjour A, Moka D, Theissen P, Lauterbach KW, Schicha H.
    Eur J Nucl Med; 2000 Oct; 27(10):1441-56. PubMed ID: 11083532
    [Abstract] [Full Text] [Related]

  • 3. Analysis models to assess cost effectiveness of the four strategies for the work-up of solitary pulmonary nodules.
    Tsushima Y, Endo K.
    Med Sci Monit; 2004 May; 10(5):MT65-72. PubMed ID: 15114278
    [Abstract] [Full Text] [Related]

  • 4. Solitary pulmonary nodules: impact of quantitative contrast-enhanced CT on the cost-effectiveness of FDG-PET.
    Comber LA, Keith CJ, Griffiths M, Miles KA.
    Clin Radiol; 2003 Sep; 58(9):706-11. PubMed ID: 12943643
    [Abstract] [Full Text] [Related]

  • 5. [Whether and under what conditions FDG-PET might be cost-effective in evaluating solitary pulmonary nodules depicted on lung cancer screening in Japan].
    Tsushima Y, Aoki J, Endo K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Sep; 63(8):390-8. PubMed ID: 14587408
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.
    Gould MK, Sanders GD, Barnett PG, Rydzak CE, Maclean CC, McClellan MB, Owens DK.
    Ann Intern Med; 2003 May 06; 138(9):724-35. PubMed ID: 12729427
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy.
    Gugiatti A, Grimaldi A, Rossetti C, Lucignani G, De Marchis D, Borgonovi E, Fazio F.
    Q J Nucl Med Mol Imaging; 2004 Mar 06; 48(1):49-61. PubMed ID: 15195004
    [Abstract] [Full Text] [Related]

  • 9. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
    Orlacchio A, Schillaci O, Antonelli L, D'Urso S, Sergiacomi G, Nicolì P, Simonetti G.
    Radiol Med; 2007 Mar 06; 112(2):157-73. PubMed ID: 17361379
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.
    Verboom P, van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, van Velthoven PC, Comans EF, Diepenhorst FW, van Mourik JC, Postmus PE, Boers M, Grijseels EW, Teule GJ, Uyl-de Groot CA, PLUS study group.
    Eur J Nucl Med Mol Imaging; 2003 Nov 06; 30(11):1444-9. PubMed ID: 14579081
    [Abstract] [Full Text] [Related]

  • 11. Alternative imaging strategy of solitary pulmonary nodule by FDG PET/CT: Can be imagined a tailored PET?
    Spadafora M, Evangelista L, Gridelli C, Cuocolo A.
    Eur J Radiol; 2017 May 06; 90():188-191. PubMed ID: 28583632
    [Abstract] [Full Text] [Related]

  • 12. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC, Machac J, Krynyckyi BR, Knesaurek K, Krellenstein D, Schultz B, Gribetz A, DePalo L, Teirstein A, Kim CK.
    Ann Nucl Med; 2008 Apr 06; 22(3):165-70. PubMed ID: 18498030
    [Abstract] [Full Text] [Related]

  • 13. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
    Bar-Shalom R, Kagna O, Israel O, Guralnik L.
    Cancer; 2008 Dec 01; 113(11):3213-21. PubMed ID: 18924145
    [Abstract] [Full Text] [Related]

  • 14. The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules.
    Herder GJ, Golding RP, Hoekstra OS, Comans EF, Teule GJ, Postmus PE, Smit EF.
    Eur J Nucl Med Mol Imaging; 2004 Sep 01; 31(9):1231-6. PubMed ID: 15175835
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule.
    Lejeune C, Al Zahouri K, Woronoff-Lemsi MC, Arveux P, Bernard A, Binquet C, Guillemin F.
    Eur J Health Econ; 2005 Sep 01; 6(3):203-14. PubMed ID: 15834623
    [Abstract] [Full Text] [Related]

  • 17. An approach to demonstrating cost-effectiveness of diagnostic imaging modalities in Australia illustrated by positron emission tomography.
    Miles KA.
    Australas Radiol; 2001 Feb 01; 45(1):9-18. PubMed ID: 11259966
    [Abstract] [Full Text] [Related]

  • 18. Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.
    Şahin E, Kara A, Elboğa U.
    Radiol Med; 2016 Dec 01; 121(12):944-949. PubMed ID: 27567614
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
    Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K.
    Chest; 1997 Aug 01; 112(2):416-22. PubMed ID: 9266877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.